First Interstate Bank decreased its position in Danaher Corporation (NYSE:DHR) by 5.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,785 shares of the conglomerate’s stock after selling 150 shares during the period. First Interstate Bank’s holdings in Danaher Corporation were worth $238,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Peddock Capital Advisors LLC raised its position in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares during the last quarter. Motco raised its position in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares during the last quarter. Baystate Wealth Management LLC raised its position in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares during the last quarter. Integrated Investment Consultants LLC raised its position in shares of Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock valued at $185,000 after buying an additional 393 shares during the last quarter. Finally, Cedar Wealth Management LLC raised its position in shares of Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock valued at $196,000 after buying an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 76.30% of the company’s stock.
Danaher Corporation (DHR) opened at 83.05 on Friday. The firm has a market capitalization of $57.65 billion, a P/E ratio of 25.31 and a beta of 1.05. Danaher Corporation has a one year low of $75.71 and a one year high of $88.01. The firm’s 50-day moving average price is $84.75 and its 200 day moving average price is $84.18.
Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 12.63%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.90 earnings per share. On average, equities analysts anticipate that Danaher Corporation will post $3.94 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be paid a dividend of $0.14 per share. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.67%. Danaher Corporation’s dividend payout ratio (DPR) is currently 17.83%.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/07/22/first-interstate-bank-sells-150-shares-of-danaher-corporation-nysedhr.html.
Several equities analysts have recently issued reports on the company. Wells Fargo & Company assumed coverage on Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price target on the stock. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday. Royal Bank Of Canada reiterated a “hold” rating and issued a $88.00 price target on shares of Danaher Corporation in a research note on Wednesday, July 12th. Citigroup Inc. reiterated a “buy” rating and issued a $96.00 price target (down previously from $98.00) on shares of Danaher Corporation in a research note on Friday. Finally, Zacks Investment Research lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $91.98.
In other news, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP William K. Daniel sold 17,444 shares of the firm’s stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $83.07, for a total value of $1,449,073.08. Following the transaction, the executive vice president now directly owns 132,995 shares in the company, valued at $11,047,894.65. The disclosure for this sale can be found here. 12.20% of the stock is currently owned by company insiders.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
